To form two joint venture companies
Strides Shasun has signed definitive agreements with Vivimed Labs to set up two joint venture companies, as under-The 50:50 joint venture company in India will own the USFDA approved formulation facility in Alathur, Chennai and
The 50:50 joint venture company in Singapore through Strides Pharma Global, Singapore will own certain approved ANDAs and product pipeline.
The transaction is subject to customary closing conditions and expected to close by 31 May 2017.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)